BOOST cells
KIBB01
Phase 2 small_molecule active
Quick answer
BOOST cells for Osteogenesis Imperfecta (OI) type III and severe type IV. Severe type of congenital Brittle bone disease. is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Osteogenesis Imperfecta (OI) type III and severe type IV. Severe type of congenital Brittle bone disease.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active